RE:RE:SAME OLD, SAME OLDlmao Boris!!
FORM 7 UPDATED MONTHLY PROGRESS REPORT Name of CSE Issuer: MATICA ENTERPRISES INC. (the “Issuer”). Trading Symbol: MMJ Number of Outstanding Listed Securities: 315,956,557 Date: January 20, 2020 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to separately report material information forthwith upon the information becoming known to management or to post the forms required by the CNSX Policies. If material information became known and was reported during the preceding month to which this report relates, this report should refer to the material information, the news release date and the posting date on the CNSX.ca website. This report is intended to keep investors and the market informed of the Issuer’s ongoing business and management activities that occurred during the preceding month. Do not discuss goals or future plans unless they have crystallized to the point that they are "material information" as defined in the CNSX Policies. The discussion in this report must be factual, balanced and non-promotional. General Instructions (a) Prepare this Monthly Progress Report using the format set out below. The sequence of questions must not be altered nor should questions be omitted or left unanswered. The answers to the items must be in narrative form. State when the answer to any item is negative or not applicable to the Issuer. The title to each item must precede the answer. (b) The term “Issuer” includes the Issuer and any of its subsidiaries. (c) Terms used and not defined in this form are defined or interpreted in Policy 1 – Interpretation and General Provisions. Report on Business 1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact. The Dorval facility of RoyalMax Biotechnology Canada Inc. (“RoyalMax”) continues to grow cannabis and is moving towards sales licensing. RoyalMax has submitted to Health Canada for both processing and medical sales licenses. We are awaiting Health Canada to assign a dedicated case worker to RoyalMax. The Company is moving forward on the Hemmingford facility and its plan to erect a 200,000 square foot greenhouse in the first phase of projected FORM 7 – MONTHLY PROGRESS REPORT November 14, 2008 Page 2 total of 1,000,000 square feet of combined greenhouses. The company is also reviewing plans for an outdoor grow on the Hemmingford property. The Company continues to review other cannabis opportunities. 2. Provide a general overview and discussion of the activities of management. Cannabis 2.0 is of major importance to Matica. Management continues to work towards producing edibles. The Company is also preparing for sales of topicals. 3. Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or oil and gas or other reports required under Ontario securities law. None. 4. Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production programs that have been amended or abandoned. None. 5. Describe any new business relationships entered into between the Issuer, the Issuer’s affiliates or third parties including contracts to supply products or services, joint venture agreements and licensing agreements etc. State whether the relationship is with a Related Person of the Issuer and provide details of the relationship. None. 6. Describe the expiry or termination of any contracts or agreements between the Issuer, the Issuer’s affiliates or third parties or cancellation of any financing arrangements that have been previously announced. None. 7. Describe any acquisitions by the Issuer or dispositions of the Issuer’s assets that occurred during the preceding month. Provide details of the nature of the assets acquired or disposed of and provide details of the consideration paid or payable together with a schedule of payments if applicable, and of any valuation. State how the consideration was determined and whether the acquisition was from or the disposition was to a Related Person of the Issuer and provide details of the relationship. None. 8. Describe the acquisition of new customers or loss of customers. None. 9. Describe any new developments or effects on intangible products such as brand names, circulation lists, copyrights, franchises, licenses, patents, software, subscription lists and trade-marks. None. FORM 7 – MONTHLY PROGRESS REPORT November 14, 2008 Page 3 10. Report on any employee hirings, terminations or lay-offs with details of anticipated length of lay-offs. None. 11. Report on any labour disputes and resolutions of those disputes if applicable. None. 12. Describe and provide details of legal proceedings to which the Issuer became a party, including the name of the court or agency, the date instituted, the principal parties to the proceedings, the nature of the claim, the amount claimed, if any, if the proceedings are being contested, and the present status of the proceedings. None. 13. Provide details of any indebtedness incurred or repaid by the Issuer together with the terms of such indebtedness. None. 14. Provide details of any securities issued and options or warrants granted. None. 15. Provide details of any loans to or by Related Persons. None. 16. Provide details of any changes in directors, officers or committee members. Roop Mundi has joined the BOD. Mr. Mundi is former securities lawyer and retailer of CBD products in his own right; as such he brings a unique skill set to the board of Matica. We welcome him to Matica. 17. Discuss any trends which are likely to impact the Issuer including trends in the Issuer’s market(s) or political/regulatory trends. None. FORM 7 – MONTHLY PROGRESS REPORT November 14, 2008 Page 4 Certificate Of Compliance The undersigned hereby certifies that: 1. The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this Certificate of Compliance. 2. As of the date hereof there were is no material information concerning the Issuer which has not been publicly disclosed. 3. The undersigned hereby certifies to CNSX that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all CNSX Requirements (as defined in CNSX Policy 1). 4. All of the information in this Form 7 Monthly Progress Report is true. Dated January 20, 2020 Boris Ziger Name of Director or Senior Officer Boris Ziger______________ Signature Director Official Capacity Issuer Details Name of Issuer Matica Enterprises Inc. For Month End Dec 2019 Date of Report YY/MM/DD 20/1/20 Issuer Address 44 Victoria Street Ste. 1102 Toronto, ON, M5C 1Y2 City/Province/Postal Code Toronto Issuer Fax No. Issuer Telephone No. ( 416) 304-9935 Contact Name Boris Ziger Contact Position CEO Contact Telephone No. (416) 304-9935 Contact Email Address info@maticaenterprises.com Web Site Address www.maticaenterprises.com